COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 1095: Articles 10941-10950  | Next

Longitudinal Changes of Cardiac and Aortic Imaging Phenotypes Following COVID-19 in the UK Biobank Cohort
Bai, W., Raman, B., Peterson, S. E., Neubauer, S., Raisi-Estabragh, Z., Aung, N., Harvey, N. C., Allen, N., Collins, R., Matthews, P. M.
10.1101/2021.11.04.21265918 — Posted: 2021-11-05
Evaluation of a Machine Learning Approach Utilizing Wearable Data for Prediction of SARS-CoV-2 Infection in Healthcare Workers
Hirten, R. P., Tomalin, L., Danieletto, M., Golden, E., Zweig, M., Kaur, S., Helmus, D., Biello, A., Pyzik, R., Bottinger, E. P., Keefer, L., Charney, D., Nadkarni, G., Suarez-Farinas, M., Fayad, Z. A.
10.1101/2021.11.04.21265931 — Posted: 2021-11-05 Discussion: Offsite
Inhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis
Lee, T. C., Bortolussi-Courval, E., Belga, S., Daneman, N., Chan, A. K., Hanula, R., Ezer, N., McDonald, E. G.
10.1101/2021.11.04.21265945 — Posted: 2021-11-05
The COVID19 pandemic has changed women's experiences of pregnancy in the UK
Sturrock, S. S., Turner, K., Lee-Wo, C., Greening, V., Khalil, A., Heath, P., Le Doare, K.
10.1101/2021.11.05.21265698 — Posted: 2021-11-05
A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity
Richardson, S. I., Manamela, N. P., Motsoeneng, B. M., Kaldine, H., Ayres, F., Makhado, Z., Mennen, M., Skelem, S., Williams, N., Sullivan, N. J., Misasi, J., Gray, G. G., Bekker, L.-G., Ueckermann, V., Rossouw, T., Boswell, M. T., Ntusi, N. A. B., Burgers, W. A., Moore, P. L.
10.1101/2021.11.05.21265853 — Posted: 2021-11-05
Cellular and humoral Immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
Lyski, Z. L., Kim, M. S., Xthona Lee, D., Raue, H.-P., Raghunathan, V., Griffin, J., Ryan, D., Brunton, A. E., Curlin, M. E., Slifka, M. K., Spurgeon, S. E.
10.1101/2021.11.04.21265948 — Posted: 2021-11-05
Can I Afford To Be On Campus?: Do College Students with Disabilities Understand COVID-19 Vaccination Costs?
Taylor, Z. W., Charran, C.
10.1101/2021.11.04.21265924 — Posted: 2021-11-05
Primary Care Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in School-aged Children: Trends and Disparities During the COVID-19 Pandemic
Bannett, Y., Dahlen, A., Huffman, L. C., Feldman, H. M.
10.1101/2021.11.03.21265902 — Posted: 2021-11-04
Influence of heterogeneous age-group contact patterns on critical vaccination rates for herd immunity to SARS-CoV-2
Saldana, J., Scoglio, C. M.
10.1101/2021.11.03.21265897 — Posted: 2021-11-04
The United States COVID-19 Forecast Hub dataset
Cramer, E. Y., Huang, Y., Wang, Y., Ray, E. L., Cornell, M., Bracher, J., Brennen, A., Castro Rivadeneira, A. J., Gerding, A., House, K., Jayawardena, D., Kanji, A. H., Khandelwal, A., Le, K., Niemi, J., Stark, A., Shah, A., Wattanachit, N., Zorn, M. W., Reich, N. G., US COVID-19 Forecast Hub Consortium
10.1101/2021.11.04.21265886 — Posted: 2021-11-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).